Clinical Urine Testing Comprehensive Study by Type (Dipsticks, Pregnancy & Fertility Kits, Reagents, Disposables, PoC Analyzers), Application (UTI, Diabetes, Pregnancy, Others), End-users (Hospitals, Clinics, Others), Methods (Urine test strip, Microscopic examination, Other methods) Players and Region - Global Market Outlook to 2026

Clinical Urine Testing Market by XX Submarkets | Forecast Years 2022-2027  

  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Clinical Urine Testing Market?

Clinical urine testing is an examination of urine for certain physical properties, solutes, cells, casts, crystals, organisms, or particulate matter, and primarily used for medical diagnosis. It is used to detect and manage a wide range of disorders such as kidney disorders, UTI (urinary tract infection) and diabetes. It helps in the early detection of serious diseases.

The market study is being classified by Type (Dipsticks, Pregnancy & Fertility Kits, Reagents, Disposables and PoC Analyzers), by Application (UTI, Diabetes, Pregnancy and Others) and major geographies with country level break-up.

Siemens Healthineers AG (Germany), Roche Holding AG (Switzerland), Beckman Coulter (United States), Sysmex Corporation (Japan), 77 Elektronika Kft. (Hungary), Analyticon Biotechnologies AG (Germany), ERBA Diagnostics (United States), ACON Laboratories, Inc. (United States), A. Menarini Diagnostics Ltd. (Italy) and URIT Medical Electronic Ltd. (China) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Bio-Rad Laboratories (United States) and ACON Laboratories (United States).

The companies are exploring the market by adopting expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to gain competitive advantage through combined collaborations. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Clinical Urine Testing market throughout the predicted period.

Segment Analysis
Analyst at AMA have segmented the market study of Global Clinical Urine Testing market by Type, Application and Region.

On the basis of geography, the market of Clinical Urine Testing has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • Growing Global Prevalence of Kidney Diseases and Urinary Tract Infections
  • Shift Towards Automation in Sediment Analysis
  • Growth in the Healthcare Infrastructure in Developing Regions

Market Trend
  • Increasing Adoption of Point-Of-Care Urinalysis

Restraints
  • High Cost of the Instruments

Opportunities
  • Growth in the Healthcare Industry
  • Increasing Number of Diagnostic Centres

Challenges
  • Lack of Skilled Professionals


Market Leaders and some development strategies
Abbott Laboratories announced its acquisition worth USD 5300 million with Alere Inc. to increase its business presence in the global market of urinalysis analyzers.
Bio-Rad Laboratories launched a new product called Quantify Advance Control for urinalysis testing. It is used for accurate analysis of the medical procedures in the urinalysis analyzers.


Key Target Audience
Clinical Urine Testing Instruments Providers, Raw Material Suppliers, Distributors, Emerging Companies, Research Professionals and End-users

Report Objectives / Segmentation Covered

By Type
  • Dipsticks
  • Pregnancy & Fertility Kits
  • Reagents
  • Disposables
  • PoC Analyzers
By Application
  • UTI
  • Diabetes
  • Pregnancy
  • Others
By End-users
  • Hospitals
  • Clinics
  • Others

By Methods
  • Urine test strip
  • Microscopic examination
  • Other methods

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Global Prevalence of Kidney Diseases and Urinary Tract Infections
      • 3.2.2. Shift Towards Automation in Sediment Analysis
      • 3.2.3. Growth in the Healthcare Infrastructure in Developing Regions
    • 3.3. Market Challenges
      • 3.3.1. Lack of Skilled Professionals
    • 3.4. Market Trends
      • 3.4.1. Increasing Adoption of Point-Of-Care Urinalysis
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Clinical Urine Testing, by Type, Application, End-users, Methods and Region (value, volume and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Clinical Urine Testing (Value)
      • 5.2.1. Global Clinical Urine Testing by: Type (Value)
        • 5.2.1.1. Dipsticks
        • 5.2.1.2. Pregnancy & Fertility Kits
        • 5.2.1.3. Reagents
        • 5.2.1.4. Disposables
        • 5.2.1.5. PoC Analyzers
      • 5.2.2. Global Clinical Urine Testing by: Application (Value)
        • 5.2.2.1. UTI
        • 5.2.2.2. Diabetes
        • 5.2.2.3. Pregnancy
        • 5.2.2.4. Others
      • 5.2.3. Global Clinical Urine Testing by: End-users (Value)
        • 5.2.3.1. Hospitals
        • 5.2.3.2. Clinics
        • 5.2.3.3. Others
      • 5.2.4. Global Clinical Urine Testing by: Methods (Value)
        • 5.2.4.1. Urine test strip
        • 5.2.4.2. Microscopic examination
        • 5.2.4.3. Other methods
      • 5.2.5. Global Clinical Urine Testing Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Clinical Urine Testing (Volume)
      • 5.3.1. Global Clinical Urine Testing by: Type (Volume)
        • 5.3.1.1. Dipsticks
        • 5.3.1.2. Pregnancy & Fertility Kits
        • 5.3.1.3. Reagents
        • 5.3.1.4. Disposables
        • 5.3.1.5. PoC Analyzers
      • 5.3.2. Global Clinical Urine Testing by: Application (Volume)
        • 5.3.2.1. UTI
        • 5.3.2.2. Diabetes
        • 5.3.2.3. Pregnancy
        • 5.3.2.4. Others
      • 5.3.3. Global Clinical Urine Testing by: End-users (Volume)
        • 5.3.3.1. Hospitals
        • 5.3.3.2. Clinics
        • 5.3.3.3. Others
      • 5.3.4. Global Clinical Urine Testing by: Methods (Volume)
        • 5.3.4.1. Urine test strip
        • 5.3.4.2. Microscopic examination
        • 5.3.4.3. Other methods
      • 5.3.5. Global Clinical Urine Testing Region
        • 5.3.5.1. South America
          • 5.3.5.1.1. Brazil
          • 5.3.5.1.2. Argentina
          • 5.3.5.1.3. Rest of South America
        • 5.3.5.2. Asia Pacific
          • 5.3.5.2.1. China
          • 5.3.5.2.2. Japan
          • 5.3.5.2.3. India
          • 5.3.5.2.4. South Korea
          • 5.3.5.2.5. Taiwan
          • 5.3.5.2.6. Australia
          • 5.3.5.2.7. Rest of Asia-Pacific
        • 5.3.5.3. Europe
          • 5.3.5.3.1. Germany
          • 5.3.5.3.2. France
          • 5.3.5.3.3. Italy
          • 5.3.5.3.4. United Kingdom
          • 5.3.5.3.5. Netherlands
          • 5.3.5.3.6. Rest of Europe
        • 5.3.5.4. MEA
          • 5.3.5.4.1. Middle East
          • 5.3.5.4.2. Africa
        • 5.3.5.5. North America
          • 5.3.5.5.1. United States
          • 5.3.5.5.2. Canada
          • 5.3.5.5.3. Mexico
    • 5.4. Global Clinical Urine Testing (Price)
      • 5.4.1. Global Clinical Urine Testing by: Type (Price)
  • 6. Clinical Urine Testing: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Siemens Healthineers AG (Germany)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Roche Holding AG (Switzerland)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Beckman Coulter (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Sysmex Corporation (Japan)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. 77 Elektronika Kft. (Hungary)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Analyticon Biotechnologies AG (Germany)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. ERBA Diagnostics (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. ACON Laboratories, Inc. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. A. Menarini Diagnostics Ltd. (Italy)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. URIT Medical Electronic Ltd. (China)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Clinical Urine Testing Sale, by Type, Application, End-users, Methods and Region (value, volume and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Clinical Urine Testing (Value)
      • 7.2.1. Global Clinical Urine Testing by: Type (Value)
        • 7.2.1.1. Dipsticks
        • 7.2.1.2. Pregnancy & Fertility Kits
        • 7.2.1.3. Reagents
        • 7.2.1.4. Disposables
        • 7.2.1.5. PoC Analyzers
      • 7.2.2. Global Clinical Urine Testing by: Application (Value)
        • 7.2.2.1. UTI
        • 7.2.2.2. Diabetes
        • 7.2.2.3. Pregnancy
        • 7.2.2.4. Others
      • 7.2.3. Global Clinical Urine Testing by: End-users (Value)
        • 7.2.3.1. Hospitals
        • 7.2.3.2. Clinics
        • 7.2.3.3. Others
      • 7.2.4. Global Clinical Urine Testing by: Methods (Value)
        • 7.2.4.1. Urine test strip
        • 7.2.4.2. Microscopic examination
        • 7.2.4.3. Other methods
      • 7.2.5. Global Clinical Urine Testing Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Clinical Urine Testing (Volume)
      • 7.3.1. Global Clinical Urine Testing by: Type (Volume)
        • 7.3.1.1. Dipsticks
        • 7.3.1.2. Pregnancy & Fertility Kits
        • 7.3.1.3. Reagents
        • 7.3.1.4. Disposables
        • 7.3.1.5. PoC Analyzers
      • 7.3.2. Global Clinical Urine Testing by: Application (Volume)
        • 7.3.2.1. UTI
        • 7.3.2.2. Diabetes
        • 7.3.2.3. Pregnancy
        • 7.3.2.4. Others
      • 7.3.3. Global Clinical Urine Testing by: End-users (Volume)
        • 7.3.3.1. Hospitals
        • 7.3.3.2. Clinics
        • 7.3.3.3. Others
      • 7.3.4. Global Clinical Urine Testing by: Methods (Volume)
        • 7.3.4.1. Urine test strip
        • 7.3.4.2. Microscopic examination
        • 7.3.4.3. Other methods
      • 7.3.5. Global Clinical Urine Testing Region
        • 7.3.5.1. South America
          • 7.3.5.1.1. Brazil
          • 7.3.5.1.2. Argentina
          • 7.3.5.1.3. Rest of South America
        • 7.3.5.2. Asia Pacific
          • 7.3.5.2.1. China
          • 7.3.5.2.2. Japan
          • 7.3.5.2.3. India
          • 7.3.5.2.4. South Korea
          • 7.3.5.2.5. Taiwan
          • 7.3.5.2.6. Australia
          • 7.3.5.2.7. Rest of Asia-Pacific
        • 7.3.5.3. Europe
          • 7.3.5.3.1. Germany
          • 7.3.5.3.2. France
          • 7.3.5.3.3. Italy
          • 7.3.5.3.4. United Kingdom
          • 7.3.5.3.5. Netherlands
          • 7.3.5.3.6. Rest of Europe
        • 7.3.5.4. MEA
          • 7.3.5.4.1. Middle East
          • 7.3.5.4.2. Africa
        • 7.3.5.5. North America
          • 7.3.5.5.1. United States
          • 7.3.5.5.2. Canada
          • 7.3.5.5.3. Mexico
    • 7.4. Global Clinical Urine Testing (Price)
      • 7.4.1. Global Clinical Urine Testing by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Clinical Urine Testing: by Type(USD Million)
  • Table 2. Clinical Urine Testing Dipsticks , by Region USD Million (2015-2020)
  • Table 3. Clinical Urine Testing Pregnancy & Fertility Kits , by Region USD Million (2015-2020)
  • Table 4. Clinical Urine Testing Reagents , by Region USD Million (2015-2020)
  • Table 5. Clinical Urine Testing Disposables , by Region USD Million (2015-2020)
  • Table 6. Clinical Urine Testing PoC Analyzers , by Region USD Million (2015-2020)
  • Table 7. Clinical Urine Testing: by Application(USD Million)
  • Table 8. Clinical Urine Testing UTI , by Region USD Million (2015-2020)
  • Table 9. Clinical Urine Testing Diabetes , by Region USD Million (2015-2020)
  • Table 10. Clinical Urine Testing Pregnancy , by Region USD Million (2015-2020)
  • Table 11. Clinical Urine Testing Others , by Region USD Million (2015-2020)
  • Table 12. Clinical Urine Testing: by End-users(USD Million)
  • Table 13. Clinical Urine Testing Hospitals , by Region USD Million (2015-2020)
  • Table 14. Clinical Urine Testing Clinics , by Region USD Million (2015-2020)
  • Table 15. Clinical Urine Testing Others , by Region USD Million (2015-2020)
  • Table 16. Clinical Urine Testing: by Methods(USD Million)
  • Table 17. Clinical Urine Testing Urine test strip , by Region USD Million (2015-2020)
  • Table 18. Clinical Urine Testing Microscopic examination , by Region USD Million (2015-2020)
  • Table 19. Clinical Urine Testing Other methods , by Region USD Million (2015-2020)
  • Table 20. South America Clinical Urine Testing, by Country USD Million (2015-2020)
  • Table 21. South America Clinical Urine Testing, by Type USD Million (2015-2020)
  • Table 22. South America Clinical Urine Testing, by Application USD Million (2015-2020)
  • Table 23. South America Clinical Urine Testing, by End-users USD Million (2015-2020)
  • Table 24. South America Clinical Urine Testing, by Methods USD Million (2015-2020)
  • Table 25. Brazil Clinical Urine Testing, by Type USD Million (2015-2020)
  • Table 26. Brazil Clinical Urine Testing, by Application USD Million (2015-2020)
  • Table 27. Brazil Clinical Urine Testing, by End-users USD Million (2015-2020)
  • Table 28. Brazil Clinical Urine Testing, by Methods USD Million (2015-2020)
  • Table 29. Argentina Clinical Urine Testing, by Type USD Million (2015-2020)
  • Table 30. Argentina Clinical Urine Testing, by Application USD Million (2015-2020)
  • Table 31. Argentina Clinical Urine Testing, by End-users USD Million (2015-2020)
  • Table 32. Argentina Clinical Urine Testing, by Methods USD Million (2015-2020)
  • Table 33. Rest of South America Clinical Urine Testing, by Type USD Million (2015-2020)
  • Table 34. Rest of South America Clinical Urine Testing, by Application USD Million (2015-2020)
  • Table 35. Rest of South America Clinical Urine Testing, by End-users USD Million (2015-2020)
  • Table 36. Rest of South America Clinical Urine Testing, by Methods USD Million (2015-2020)
  • Table 37. Asia Pacific Clinical Urine Testing, by Country USD Million (2015-2020)
  • Table 38. Asia Pacific Clinical Urine Testing, by Type USD Million (2015-2020)
  • Table 39. Asia Pacific Clinical Urine Testing, by Application USD Million (2015-2020)
  • Table 40. Asia Pacific Clinical Urine Testing, by End-users USD Million (2015-2020)
  • Table 41. Asia Pacific Clinical Urine Testing, by Methods USD Million (2015-2020)
  • Table 42. China Clinical Urine Testing, by Type USD Million (2015-2020)
  • Table 43. China Clinical Urine Testing, by Application USD Million (2015-2020)
  • Table 44. China Clinical Urine Testing, by End-users USD Million (2015-2020)
  • Table 45. China Clinical Urine Testing, by Methods USD Million (2015-2020)
  • Table 46. Japan Clinical Urine Testing, by Type USD Million (2015-2020)
  • Table 47. Japan Clinical Urine Testing, by Application USD Million (2015-2020)
  • Table 48. Japan Clinical Urine Testing, by End-users USD Million (2015-2020)
  • Table 49. Japan Clinical Urine Testing, by Methods USD Million (2015-2020)
  • Table 50. India Clinical Urine Testing, by Type USD Million (2015-2020)
  • Table 51. India Clinical Urine Testing, by Application USD Million (2015-2020)
  • Table 52. India Clinical Urine Testing, by End-users USD Million (2015-2020)
  • Table 53. India Clinical Urine Testing, by Methods USD Million (2015-2020)
  • Table 54. South Korea Clinical Urine Testing, by Type USD Million (2015-2020)
  • Table 55. South Korea Clinical Urine Testing, by Application USD Million (2015-2020)
  • Table 56. South Korea Clinical Urine Testing, by End-users USD Million (2015-2020)
  • Table 57. South Korea Clinical Urine Testing, by Methods USD Million (2015-2020)
  • Table 58. Taiwan Clinical Urine Testing, by Type USD Million (2015-2020)
  • Table 59. Taiwan Clinical Urine Testing, by Application USD Million (2015-2020)
  • Table 60. Taiwan Clinical Urine Testing, by End-users USD Million (2015-2020)
  • Table 61. Taiwan Clinical Urine Testing, by Methods USD Million (2015-2020)
  • Table 62. Australia Clinical Urine Testing, by Type USD Million (2015-2020)
  • Table 63. Australia Clinical Urine Testing, by Application USD Million (2015-2020)
  • Table 64. Australia Clinical Urine Testing, by End-users USD Million (2015-2020)
  • Table 65. Australia Clinical Urine Testing, by Methods USD Million (2015-2020)
  • Table 66. Rest of Asia-Pacific Clinical Urine Testing, by Type USD Million (2015-2020)
  • Table 67. Rest of Asia-Pacific Clinical Urine Testing, by Application USD Million (2015-2020)
  • Table 68. Rest of Asia-Pacific Clinical Urine Testing, by End-users USD Million (2015-2020)
  • Table 69. Rest of Asia-Pacific Clinical Urine Testing, by Methods USD Million (2015-2020)
  • Table 70. Europe Clinical Urine Testing, by Country USD Million (2015-2020)
  • Table 71. Europe Clinical Urine Testing, by Type USD Million (2015-2020)
  • Table 72. Europe Clinical Urine Testing, by Application USD Million (2015-2020)
  • Table 73. Europe Clinical Urine Testing, by End-users USD Million (2015-2020)
  • Table 74. Europe Clinical Urine Testing, by Methods USD Million (2015-2020)
  • Table 75. Germany Clinical Urine Testing, by Type USD Million (2015-2020)
  • Table 76. Germany Clinical Urine Testing, by Application USD Million (2015-2020)
  • Table 77. Germany Clinical Urine Testing, by End-users USD Million (2015-2020)
  • Table 78. Germany Clinical Urine Testing, by Methods USD Million (2015-2020)
  • Table 79. France Clinical Urine Testing, by Type USD Million (2015-2020)
  • Table 80. France Clinical Urine Testing, by Application USD Million (2015-2020)
  • Table 81. France Clinical Urine Testing, by End-users USD Million (2015-2020)
  • Table 82. France Clinical Urine Testing, by Methods USD Million (2015-2020)
  • Table 83. Italy Clinical Urine Testing, by Type USD Million (2015-2020)
  • Table 84. Italy Clinical Urine Testing, by Application USD Million (2015-2020)
  • Table 85. Italy Clinical Urine Testing, by End-users USD Million (2015-2020)
  • Table 86. Italy Clinical Urine Testing, by Methods USD Million (2015-2020)
  • Table 87. United Kingdom Clinical Urine Testing, by Type USD Million (2015-2020)
  • Table 88. United Kingdom Clinical Urine Testing, by Application USD Million (2015-2020)
  • Table 89. United Kingdom Clinical Urine Testing, by End-users USD Million (2015-2020)
  • Table 90. United Kingdom Clinical Urine Testing, by Methods USD Million (2015-2020)
  • Table 91. Netherlands Clinical Urine Testing, by Type USD Million (2015-2020)
  • Table 92. Netherlands Clinical Urine Testing, by Application USD Million (2015-2020)
  • Table 93. Netherlands Clinical Urine Testing, by End-users USD Million (2015-2020)
  • Table 94. Netherlands Clinical Urine Testing, by Methods USD Million (2015-2020)
  • Table 95. Rest of Europe Clinical Urine Testing, by Type USD Million (2015-2020)
  • Table 96. Rest of Europe Clinical Urine Testing, by Application USD Million (2015-2020)
  • Table 97. Rest of Europe Clinical Urine Testing, by End-users USD Million (2015-2020)
  • Table 98. Rest of Europe Clinical Urine Testing, by Methods USD Million (2015-2020)
  • Table 99. MEA Clinical Urine Testing, by Country USD Million (2015-2020)
  • Table 100. MEA Clinical Urine Testing, by Type USD Million (2015-2020)
  • Table 101. MEA Clinical Urine Testing, by Application USD Million (2015-2020)
  • Table 102. MEA Clinical Urine Testing, by End-users USD Million (2015-2020)
  • Table 103. MEA Clinical Urine Testing, by Methods USD Million (2015-2020)
  • Table 104. Middle East Clinical Urine Testing, by Type USD Million (2015-2020)
  • Table 105. Middle East Clinical Urine Testing, by Application USD Million (2015-2020)
  • Table 106. Middle East Clinical Urine Testing, by End-users USD Million (2015-2020)
  • Table 107. Middle East Clinical Urine Testing, by Methods USD Million (2015-2020)
  • Table 108. Africa Clinical Urine Testing, by Type USD Million (2015-2020)
  • Table 109. Africa Clinical Urine Testing, by Application USD Million (2015-2020)
  • Table 110. Africa Clinical Urine Testing, by End-users USD Million (2015-2020)
  • Table 111. Africa Clinical Urine Testing, by Methods USD Million (2015-2020)
  • Table 112. North America Clinical Urine Testing, by Country USD Million (2015-2020)
  • Table 113. North America Clinical Urine Testing, by Type USD Million (2015-2020)
  • Table 114. North America Clinical Urine Testing, by Application USD Million (2015-2020)
  • Table 115. North America Clinical Urine Testing, by End-users USD Million (2015-2020)
  • Table 116. North America Clinical Urine Testing, by Methods USD Million (2015-2020)
  • Table 117. United States Clinical Urine Testing, by Type USD Million (2015-2020)
  • Table 118. United States Clinical Urine Testing, by Application USD Million (2015-2020)
  • Table 119. United States Clinical Urine Testing, by End-users USD Million (2015-2020)
  • Table 120. United States Clinical Urine Testing, by Methods USD Million (2015-2020)
  • Table 121. Canada Clinical Urine Testing, by Type USD Million (2015-2020)
  • Table 122. Canada Clinical Urine Testing, by Application USD Million (2015-2020)
  • Table 123. Canada Clinical Urine Testing, by End-users USD Million (2015-2020)
  • Table 124. Canada Clinical Urine Testing, by Methods USD Million (2015-2020)
  • Table 125. Mexico Clinical Urine Testing, by Type USD Million (2015-2020)
  • Table 126. Mexico Clinical Urine Testing, by Application USD Million (2015-2020)
  • Table 127. Mexico Clinical Urine Testing, by End-users USD Million (2015-2020)
  • Table 128. Mexico Clinical Urine Testing, by Methods USD Million (2015-2020)
  • Table 129. Clinical Urine Testing Sales: by Type(K Units)
  • Table 130. Clinical Urine Testing Sales Dipsticks , by Region K Units (2015-2020)
  • Table 131. Clinical Urine Testing Sales Pregnancy & Fertility Kits , by Region K Units (2015-2020)
  • Table 132. Clinical Urine Testing Sales Reagents , by Region K Units (2015-2020)
  • Table 133. Clinical Urine Testing Sales Disposables , by Region K Units (2015-2020)
  • Table 134. Clinical Urine Testing Sales PoC Analyzers , by Region K Units (2015-2020)
  • Table 135. Clinical Urine Testing Sales: by Application(K Units)
  • Table 136. Clinical Urine Testing Sales UTI , by Region K Units (2015-2020)
  • Table 137. Clinical Urine Testing Sales Diabetes , by Region K Units (2015-2020)
  • Table 138. Clinical Urine Testing Sales Pregnancy , by Region K Units (2015-2020)
  • Table 139. Clinical Urine Testing Sales Others , by Region K Units (2015-2020)
  • Table 140. Clinical Urine Testing Sales: by End-users(K Units)
  • Table 141. Clinical Urine Testing Sales Hospitals , by Region K Units (2015-2020)
  • Table 142. Clinical Urine Testing Sales Clinics , by Region K Units (2015-2020)
  • Table 143. Clinical Urine Testing Sales Others , by Region K Units (2015-2020)
  • Table 144. Clinical Urine Testing Sales: by Methods(K Units)
  • Table 145. Clinical Urine Testing Sales Urine test strip , by Region K Units (2015-2020)
  • Table 146. Clinical Urine Testing Sales Microscopic examination , by Region K Units (2015-2020)
  • Table 147. Clinical Urine Testing Sales Other methods , by Region K Units (2015-2020)
  • Table 148. South America Clinical Urine Testing Sales, by Country K Units (2015-2020)
  • Table 149. South America Clinical Urine Testing Sales, by Type K Units (2015-2020)
  • Table 150. South America Clinical Urine Testing Sales, by Application K Units (2015-2020)
  • Table 151. South America Clinical Urine Testing Sales, by End-users K Units (2015-2020)
  • Table 152. South America Clinical Urine Testing Sales, by Methods K Units (2015-2020)
  • Table 153. Brazil Clinical Urine Testing Sales, by Type K Units (2015-2020)
  • Table 154. Brazil Clinical Urine Testing Sales, by Application K Units (2015-2020)
  • Table 155. Brazil Clinical Urine Testing Sales, by End-users K Units (2015-2020)
  • Table 156. Brazil Clinical Urine Testing Sales, by Methods K Units (2015-2020)
  • Table 157. Argentina Clinical Urine Testing Sales, by Type K Units (2015-2020)
  • Table 158. Argentina Clinical Urine Testing Sales, by Application K Units (2015-2020)
  • Table 159. Argentina Clinical Urine Testing Sales, by End-users K Units (2015-2020)
  • Table 160. Argentina Clinical Urine Testing Sales, by Methods K Units (2015-2020)
  • Table 161. Rest of South America Clinical Urine Testing Sales, by Type K Units (2015-2020)
  • Table 162. Rest of South America Clinical Urine Testing Sales, by Application K Units (2015-2020)
  • Table 163. Rest of South America Clinical Urine Testing Sales, by End-users K Units (2015-2020)
  • Table 164. Rest of South America Clinical Urine Testing Sales, by Methods K Units (2015-2020)
  • Table 165. Asia Pacific Clinical Urine Testing Sales, by Country K Units (2015-2020)
  • Table 166. Asia Pacific Clinical Urine Testing Sales, by Type K Units (2015-2020)
  • Table 167. Asia Pacific Clinical Urine Testing Sales, by Application K Units (2015-2020)
  • Table 168. Asia Pacific Clinical Urine Testing Sales, by End-users K Units (2015-2020)
  • Table 169. Asia Pacific Clinical Urine Testing Sales, by Methods K Units (2015-2020)
  • Table 170. China Clinical Urine Testing Sales, by Type K Units (2015-2020)
  • Table 171. China Clinical Urine Testing Sales, by Application K Units (2015-2020)
  • Table 172. China Clinical Urine Testing Sales, by End-users K Units (2015-2020)
  • Table 173. China Clinical Urine Testing Sales, by Methods K Units (2015-2020)
  • Table 174. Japan Clinical Urine Testing Sales, by Type K Units (2015-2020)
  • Table 175. Japan Clinical Urine Testing Sales, by Application K Units (2015-2020)
  • Table 176. Japan Clinical Urine Testing Sales, by End-users K Units (2015-2020)
  • Table 177. Japan Clinical Urine Testing Sales, by Methods K Units (2015-2020)
  • Table 178. India Clinical Urine Testing Sales, by Type K Units (2015-2020)
  • Table 179. India Clinical Urine Testing Sales, by Application K Units (2015-2020)
  • Table 180. India Clinical Urine Testing Sales, by End-users K Units (2015-2020)
  • Table 181. India Clinical Urine Testing Sales, by Methods K Units (2015-2020)
  • Table 182. South Korea Clinical Urine Testing Sales, by Type K Units (2015-2020)
  • Table 183. South Korea Clinical Urine Testing Sales, by Application K Units (2015-2020)
  • Table 184. South Korea Clinical Urine Testing Sales, by End-users K Units (2015-2020)
  • Table 185. South Korea Clinical Urine Testing Sales, by Methods K Units (2015-2020)
  • Table 186. Taiwan Clinical Urine Testing Sales, by Type K Units (2015-2020)
  • Table 187. Taiwan Clinical Urine Testing Sales, by Application K Units (2015-2020)
  • Table 188. Taiwan Clinical Urine Testing Sales, by End-users K Units (2015-2020)
  • Table 189. Taiwan Clinical Urine Testing Sales, by Methods K Units (2015-2020)
  • Table 190. Australia Clinical Urine Testing Sales, by Type K Units (2015-2020)
  • Table 191. Australia Clinical Urine Testing Sales, by Application K Units (2015-2020)
  • Table 192. Australia Clinical Urine Testing Sales, by End-users K Units (2015-2020)
  • Table 193. Australia Clinical Urine Testing Sales, by Methods K Units (2015-2020)
  • Table 194. Rest of Asia-Pacific Clinical Urine Testing Sales, by Type K Units (2015-2020)
  • Table 195. Rest of Asia-Pacific Clinical Urine Testing Sales, by Application K Units (2015-2020)
  • Table 196. Rest of Asia-Pacific Clinical Urine Testing Sales, by End-users K Units (2015-2020)
  • Table 197. Rest of Asia-Pacific Clinical Urine Testing Sales, by Methods K Units (2015-2020)
  • Table 198. Europe Clinical Urine Testing Sales, by Country K Units (2015-2020)
  • Table 199. Europe Clinical Urine Testing Sales, by Type K Units (2015-2020)
  • Table 200. Europe Clinical Urine Testing Sales, by Application K Units (2015-2020)
  • Table 201. Europe Clinical Urine Testing Sales, by End-users K Units (2015-2020)
  • Table 202. Europe Clinical Urine Testing Sales, by Methods K Units (2015-2020)
  • Table 203. Germany Clinical Urine Testing Sales, by Type K Units (2015-2020)
  • Table 204. Germany Clinical Urine Testing Sales, by Application K Units (2015-2020)
  • Table 205. Germany Clinical Urine Testing Sales, by End-users K Units (2015-2020)
  • Table 206. Germany Clinical Urine Testing Sales, by Methods K Units (2015-2020)
  • Table 207. France Clinical Urine Testing Sales, by Type K Units (2015-2020)
  • Table 208. France Clinical Urine Testing Sales, by Application K Units (2015-2020)
  • Table 209. France Clinical Urine Testing Sales, by End-users K Units (2015-2020)
  • Table 210. France Clinical Urine Testing Sales, by Methods K Units (2015-2020)
  • Table 211. Italy Clinical Urine Testing Sales, by Type K Units (2015-2020)
  • Table 212. Italy Clinical Urine Testing Sales, by Application K Units (2015-2020)
  • Table 213. Italy Clinical Urine Testing Sales, by End-users K Units (2015-2020)
  • Table 214. Italy Clinical Urine Testing Sales, by Methods K Units (2015-2020)
  • Table 215. United Kingdom Clinical Urine Testing Sales, by Type K Units (2015-2020)
  • Table 216. United Kingdom Clinical Urine Testing Sales, by Application K Units (2015-2020)
  • Table 217. United Kingdom Clinical Urine Testing Sales, by End-users K Units (2015-2020)
  • Table 218. United Kingdom Clinical Urine Testing Sales, by Methods K Units (2015-2020)
  • Table 219. Netherlands Clinical Urine Testing Sales, by Type K Units (2015-2020)
  • Table 220. Netherlands Clinical Urine Testing Sales, by Application K Units (2015-2020)
  • Table 221. Netherlands Clinical Urine Testing Sales, by End-users K Units (2015-2020)
  • Table 222. Netherlands Clinical Urine Testing Sales, by Methods K Units (2015-2020)
  • Table 223. Rest of Europe Clinical Urine Testing Sales, by Type K Units (2015-2020)
  • Table 224. Rest of Europe Clinical Urine Testing Sales, by Application K Units (2015-2020)
  • Table 225. Rest of Europe Clinical Urine Testing Sales, by End-users K Units (2015-2020)
  • Table 226. Rest of Europe Clinical Urine Testing Sales, by Methods K Units (2015-2020)
  • Table 227. MEA Clinical Urine Testing Sales, by Country K Units (2015-2020)
  • Table 228. MEA Clinical Urine Testing Sales, by Type K Units (2015-2020)
  • Table 229. MEA Clinical Urine Testing Sales, by Application K Units (2015-2020)
  • Table 230. MEA Clinical Urine Testing Sales, by End-users K Units (2015-2020)
  • Table 231. MEA Clinical Urine Testing Sales, by Methods K Units (2015-2020)
  • Table 232. Middle East Clinical Urine Testing Sales, by Type K Units (2015-2020)
  • Table 233. Middle East Clinical Urine Testing Sales, by Application K Units (2015-2020)
  • Table 234. Middle East Clinical Urine Testing Sales, by End-users K Units (2015-2020)
  • Table 235. Middle East Clinical Urine Testing Sales, by Methods K Units (2015-2020)
  • Table 236. Africa Clinical Urine Testing Sales, by Type K Units (2015-2020)
  • Table 237. Africa Clinical Urine Testing Sales, by Application K Units (2015-2020)
  • Table 238. Africa Clinical Urine Testing Sales, by End-users K Units (2015-2020)
  • Table 239. Africa Clinical Urine Testing Sales, by Methods K Units (2015-2020)
  • Table 240. North America Clinical Urine Testing Sales, by Country K Units (2015-2020)
  • Table 241. North America Clinical Urine Testing Sales, by Type K Units (2015-2020)
  • Table 242. North America Clinical Urine Testing Sales, by Application K Units (2015-2020)
  • Table 243. North America Clinical Urine Testing Sales, by End-users K Units (2015-2020)
  • Table 244. North America Clinical Urine Testing Sales, by Methods K Units (2015-2020)
  • Table 245. United States Clinical Urine Testing Sales, by Type K Units (2015-2020)
  • Table 246. United States Clinical Urine Testing Sales, by Application K Units (2015-2020)
  • Table 247. United States Clinical Urine Testing Sales, by End-users K Units (2015-2020)
  • Table 248. United States Clinical Urine Testing Sales, by Methods K Units (2015-2020)
  • Table 249. Canada Clinical Urine Testing Sales, by Type K Units (2015-2020)
  • Table 250. Canada Clinical Urine Testing Sales, by Application K Units (2015-2020)
  • Table 251. Canada Clinical Urine Testing Sales, by End-users K Units (2015-2020)
  • Table 252. Canada Clinical Urine Testing Sales, by Methods K Units (2015-2020)
  • Table 253. Mexico Clinical Urine Testing Sales, by Type K Units (2015-2020)
  • Table 254. Mexico Clinical Urine Testing Sales, by Application K Units (2015-2020)
  • Table 255. Mexico Clinical Urine Testing Sales, by End-users K Units (2015-2020)
  • Table 256. Mexico Clinical Urine Testing Sales, by Methods K Units (2015-2020)
  • Table 257. Clinical Urine Testing: by Type(USD/Units)
  • Table 258. Company Basic Information, Sales Area and Its Competitors
  • Table 259. Company Basic Information, Sales Area and Its Competitors
  • Table 260. Company Basic Information, Sales Area and Its Competitors
  • Table 261. Company Basic Information, Sales Area and Its Competitors
  • Table 262. Company Basic Information, Sales Area and Its Competitors
  • Table 263. Company Basic Information, Sales Area and Its Competitors
  • Table 264. Company Basic Information, Sales Area and Its Competitors
  • Table 265. Company Basic Information, Sales Area and Its Competitors
  • Table 266. Company Basic Information, Sales Area and Its Competitors
  • Table 267. Company Basic Information, Sales Area and Its Competitors
  • Table 268. Clinical Urine Testing: by Type(USD Million)
  • Table 269. Clinical Urine Testing Dipsticks , by Region USD Million (2021-2026)
  • Table 270. Clinical Urine Testing Pregnancy & Fertility Kits , by Region USD Million (2021-2026)
  • Table 271. Clinical Urine Testing Reagents , by Region USD Million (2021-2026)
  • Table 272. Clinical Urine Testing Disposables , by Region USD Million (2021-2026)
  • Table 273. Clinical Urine Testing PoC Analyzers , by Region USD Million (2021-2026)
  • Table 274. Clinical Urine Testing: by Application(USD Million)
  • Table 275. Clinical Urine Testing UTI , by Region USD Million (2021-2026)
  • Table 276. Clinical Urine Testing Diabetes , by Region USD Million (2021-2026)
  • Table 277. Clinical Urine Testing Pregnancy , by Region USD Million (2021-2026)
  • Table 278. Clinical Urine Testing Others , by Region USD Million (2021-2026)
  • Table 279. Clinical Urine Testing: by End-users(USD Million)
  • Table 280. Clinical Urine Testing Hospitals , by Region USD Million (2021-2026)
  • Table 281. Clinical Urine Testing Clinics , by Region USD Million (2021-2026)
  • Table 282. Clinical Urine Testing Others , by Region USD Million (2021-2026)
  • Table 283. Clinical Urine Testing: by Methods(USD Million)
  • Table 284. Clinical Urine Testing Urine test strip , by Region USD Million (2021-2026)
  • Table 285. Clinical Urine Testing Microscopic examination , by Region USD Million (2021-2026)
  • Table 286. Clinical Urine Testing Other methods , by Region USD Million (2021-2026)
  • Table 287. South America Clinical Urine Testing, by Country USD Million (2021-2026)
  • Table 288. South America Clinical Urine Testing, by Type USD Million (2021-2026)
  • Table 289. South America Clinical Urine Testing, by Application USD Million (2021-2026)
  • Table 290. South America Clinical Urine Testing, by End-users USD Million (2021-2026)
  • Table 291. South America Clinical Urine Testing, by Methods USD Million (2021-2026)
  • Table 292. Brazil Clinical Urine Testing, by Type USD Million (2021-2026)
  • Table 293. Brazil Clinical Urine Testing, by Application USD Million (2021-2026)
  • Table 294. Brazil Clinical Urine Testing, by End-users USD Million (2021-2026)
  • Table 295. Brazil Clinical Urine Testing, by Methods USD Million (2021-2026)
  • Table 296. Argentina Clinical Urine Testing, by Type USD Million (2021-2026)
  • Table 297. Argentina Clinical Urine Testing, by Application USD Million (2021-2026)
  • Table 298. Argentina Clinical Urine Testing, by End-users USD Million (2021-2026)
  • Table 299. Argentina Clinical Urine Testing, by Methods USD Million (2021-2026)
  • Table 300. Rest of South America Clinical Urine Testing, by Type USD Million (2021-2026)
  • Table 301. Rest of South America Clinical Urine Testing, by Application USD Million (2021-2026)
  • Table 302. Rest of South America Clinical Urine Testing, by End-users USD Million (2021-2026)
  • Table 303. Rest of South America Clinical Urine Testing, by Methods USD Million (2021-2026)
  • Table 304. Asia Pacific Clinical Urine Testing, by Country USD Million (2021-2026)
  • Table 305. Asia Pacific Clinical Urine Testing, by Type USD Million (2021-2026)
  • Table 306. Asia Pacific Clinical Urine Testing, by Application USD Million (2021-2026)
  • Table 307. Asia Pacific Clinical Urine Testing, by End-users USD Million (2021-2026)
  • Table 308. Asia Pacific Clinical Urine Testing, by Methods USD Million (2021-2026)
  • Table 309. China Clinical Urine Testing, by Type USD Million (2021-2026)
  • Table 310. China Clinical Urine Testing, by Application USD Million (2021-2026)
  • Table 311. China Clinical Urine Testing, by End-users USD Million (2021-2026)
  • Table 312. China Clinical Urine Testing, by Methods USD Million (2021-2026)
  • Table 313. Japan Clinical Urine Testing, by Type USD Million (2021-2026)
  • Table 314. Japan Clinical Urine Testing, by Application USD Million (2021-2026)
  • Table 315. Japan Clinical Urine Testing, by End-users USD Million (2021-2026)
  • Table 316. Japan Clinical Urine Testing, by Methods USD Million (2021-2026)
  • Table 317. India Clinical Urine Testing, by Type USD Million (2021-2026)
  • Table 318. India Clinical Urine Testing, by Application USD Million (2021-2026)
  • Table 319. India Clinical Urine Testing, by End-users USD Million (2021-2026)
  • Table 320. India Clinical Urine Testing, by Methods USD Million (2021-2026)
  • Table 321. South Korea Clinical Urine Testing, by Type USD Million (2021-2026)
  • Table 322. South Korea Clinical Urine Testing, by Application USD Million (2021-2026)
  • Table 323. South Korea Clinical Urine Testing, by End-users USD Million (2021-2026)
  • Table 324. South Korea Clinical Urine Testing, by Methods USD Million (2021-2026)
  • Table 325. Taiwan Clinical Urine Testing, by Type USD Million (2021-2026)
  • Table 326. Taiwan Clinical Urine Testing, by Application USD Million (2021-2026)
  • Table 327. Taiwan Clinical Urine Testing, by End-users USD Million (2021-2026)
  • Table 328. Taiwan Clinical Urine Testing, by Methods USD Million (2021-2026)
  • Table 329. Australia Clinical Urine Testing, by Type USD Million (2021-2026)
  • Table 330. Australia Clinical Urine Testing, by Application USD Million (2021-2026)
  • Table 331. Australia Clinical Urine Testing, by End-users USD Million (2021-2026)
  • Table 332. Australia Clinical Urine Testing, by Methods USD Million (2021-2026)
  • Table 333. Rest of Asia-Pacific Clinical Urine Testing, by Type USD Million (2021-2026)
  • Table 334. Rest of Asia-Pacific Clinical Urine Testing, by Application USD Million (2021-2026)
  • Table 335. Rest of Asia-Pacific Clinical Urine Testing, by End-users USD Million (2021-2026)
  • Table 336. Rest of Asia-Pacific Clinical Urine Testing, by Methods USD Million (2021-2026)
  • Table 337. Europe Clinical Urine Testing, by Country USD Million (2021-2026)
  • Table 338. Europe Clinical Urine Testing, by Type USD Million (2021-2026)
  • Table 339. Europe Clinical Urine Testing, by Application USD Million (2021-2026)
  • Table 340. Europe Clinical Urine Testing, by End-users USD Million (2021-2026)
  • Table 341. Europe Clinical Urine Testing, by Methods USD Million (2021-2026)
  • Table 342. Germany Clinical Urine Testing, by Type USD Million (2021-2026)
  • Table 343. Germany Clinical Urine Testing, by Application USD Million (2021-2026)
  • Table 344. Germany Clinical Urine Testing, by End-users USD Million (2021-2026)
  • Table 345. Germany Clinical Urine Testing, by Methods USD Million (2021-2026)
  • Table 346. France Clinical Urine Testing, by Type USD Million (2021-2026)
  • Table 347. France Clinical Urine Testing, by Application USD Million (2021-2026)
  • Table 348. France Clinical Urine Testing, by End-users USD Million (2021-2026)
  • Table 349. France Clinical Urine Testing, by Methods USD Million (2021-2026)
  • Table 350. Italy Clinical Urine Testing, by Type USD Million (2021-2026)
  • Table 351. Italy Clinical Urine Testing, by Application USD Million (2021-2026)
  • Table 352. Italy Clinical Urine Testing, by End-users USD Million (2021-2026)
  • Table 353. Italy Clinical Urine Testing, by Methods USD Million (2021-2026)
  • Table 354. United Kingdom Clinical Urine Testing, by Type USD Million (2021-2026)
  • Table 355. United Kingdom Clinical Urine Testing, by Application USD Million (2021-2026)
  • Table 356. United Kingdom Clinical Urine Testing, by End-users USD Million (2021-2026)
  • Table 357. United Kingdom Clinical Urine Testing, by Methods USD Million (2021-2026)
  • Table 358. Netherlands Clinical Urine Testing, by Type USD Million (2021-2026)
  • Table 359. Netherlands Clinical Urine Testing, by Application USD Million (2021-2026)
  • Table 360. Netherlands Clinical Urine Testing, by End-users USD Million (2021-2026)
  • Table 361. Netherlands Clinical Urine Testing, by Methods USD Million (2021-2026)
  • Table 362. Rest of Europe Clinical Urine Testing, by Type USD Million (2021-2026)
  • Table 363. Rest of Europe Clinical Urine Testing, by Application USD Million (2021-2026)
  • Table 364. Rest of Europe Clinical Urine Testing, by End-users USD Million (2021-2026)
  • Table 365. Rest of Europe Clinical Urine Testing, by Methods USD Million (2021-2026)
  • Table 366. MEA Clinical Urine Testing, by Country USD Million (2021-2026)
  • Table 367. MEA Clinical Urine Testing, by Type USD Million (2021-2026)
  • Table 368. MEA Clinical Urine Testing, by Application USD Million (2021-2026)
  • Table 369. MEA Clinical Urine Testing, by End-users USD Million (2021-2026)
  • Table 370. MEA Clinical Urine Testing, by Methods USD Million (2021-2026)
  • Table 371. Middle East Clinical Urine Testing, by Type USD Million (2021-2026)
  • Table 372. Middle East Clinical Urine Testing, by Application USD Million (2021-2026)
  • Table 373. Middle East Clinical Urine Testing, by End-users USD Million (2021-2026)
  • Table 374. Middle East Clinical Urine Testing, by Methods USD Million (2021-2026)
  • Table 375. Africa Clinical Urine Testing, by Type USD Million (2021-2026)
  • Table 376. Africa Clinical Urine Testing, by Application USD Million (2021-2026)
  • Table 377. Africa Clinical Urine Testing, by End-users USD Million (2021-2026)
  • Table 378. Africa Clinical Urine Testing, by Methods USD Million (2021-2026)
  • Table 379. North America Clinical Urine Testing, by Country USD Million (2021-2026)
  • Table 380. North America Clinical Urine Testing, by Type USD Million (2021-2026)
  • Table 381. North America Clinical Urine Testing, by Application USD Million (2021-2026)
  • Table 382. North America Clinical Urine Testing, by End-users USD Million (2021-2026)
  • Table 383. North America Clinical Urine Testing, by Methods USD Million (2021-2026)
  • Table 384. United States Clinical Urine Testing, by Type USD Million (2021-2026)
  • Table 385. United States Clinical Urine Testing, by Application USD Million (2021-2026)
  • Table 386. United States Clinical Urine Testing, by End-users USD Million (2021-2026)
  • Table 387. United States Clinical Urine Testing, by Methods USD Million (2021-2026)
  • Table 388. Canada Clinical Urine Testing, by Type USD Million (2021-2026)
  • Table 389. Canada Clinical Urine Testing, by Application USD Million (2021-2026)
  • Table 390. Canada Clinical Urine Testing, by End-users USD Million (2021-2026)
  • Table 391. Canada Clinical Urine Testing, by Methods USD Million (2021-2026)
  • Table 392. Mexico Clinical Urine Testing, by Type USD Million (2021-2026)
  • Table 393. Mexico Clinical Urine Testing, by Application USD Million (2021-2026)
  • Table 394. Mexico Clinical Urine Testing, by End-users USD Million (2021-2026)
  • Table 395. Mexico Clinical Urine Testing, by Methods USD Million (2021-2026)
  • Table 396. Clinical Urine Testing Sales: by Type(K Units)
  • Table 397. Clinical Urine Testing Sales Dipsticks , by Region K Units (2021-2026)
  • Table 398. Clinical Urine Testing Sales Pregnancy & Fertility Kits , by Region K Units (2021-2026)
  • Table 399. Clinical Urine Testing Sales Reagents , by Region K Units (2021-2026)
  • Table 400. Clinical Urine Testing Sales Disposables , by Region K Units (2021-2026)
  • Table 401. Clinical Urine Testing Sales PoC Analyzers , by Region K Units (2021-2026)
  • Table 402. Clinical Urine Testing Sales: by Application(K Units)
  • Table 403. Clinical Urine Testing Sales UTI , by Region K Units (2021-2026)
  • Table 404. Clinical Urine Testing Sales Diabetes , by Region K Units (2021-2026)
  • Table 405. Clinical Urine Testing Sales Pregnancy , by Region K Units (2021-2026)
  • Table 406. Clinical Urine Testing Sales Others , by Region K Units (2021-2026)
  • Table 407. Clinical Urine Testing Sales: by End-users(K Units)
  • Table 408. Clinical Urine Testing Sales Hospitals , by Region K Units (2021-2026)
  • Table 409. Clinical Urine Testing Sales Clinics , by Region K Units (2021-2026)
  • Table 410. Clinical Urine Testing Sales Others , by Region K Units (2021-2026)
  • Table 411. Clinical Urine Testing Sales: by Methods(K Units)
  • Table 412. Clinical Urine Testing Sales Urine test strip , by Region K Units (2021-2026)
  • Table 413. Clinical Urine Testing Sales Microscopic examination , by Region K Units (2021-2026)
  • Table 414. Clinical Urine Testing Sales Other methods , by Region K Units (2021-2026)
  • Table 415. South America Clinical Urine Testing Sales, by Country K Units (2021-2026)
  • Table 416. South America Clinical Urine Testing Sales, by Type K Units (2021-2026)
  • Table 417. South America Clinical Urine Testing Sales, by Application K Units (2021-2026)
  • Table 418. South America Clinical Urine Testing Sales, by End-users K Units (2021-2026)
  • Table 419. South America Clinical Urine Testing Sales, by Methods K Units (2021-2026)
  • Table 420. Brazil Clinical Urine Testing Sales, by Type K Units (2021-2026)
  • Table 421. Brazil Clinical Urine Testing Sales, by Application K Units (2021-2026)
  • Table 422. Brazil Clinical Urine Testing Sales, by End-users K Units (2021-2026)
  • Table 423. Brazil Clinical Urine Testing Sales, by Methods K Units (2021-2026)
  • Table 424. Argentina Clinical Urine Testing Sales, by Type K Units (2021-2026)
  • Table 425. Argentina Clinical Urine Testing Sales, by Application K Units (2021-2026)
  • Table 426. Argentina Clinical Urine Testing Sales, by End-users K Units (2021-2026)
  • Table 427. Argentina Clinical Urine Testing Sales, by Methods K Units (2021-2026)
  • Table 428. Rest of South America Clinical Urine Testing Sales, by Type K Units (2021-2026)
  • Table 429. Rest of South America Clinical Urine Testing Sales, by Application K Units (2021-2026)
  • Table 430. Rest of South America Clinical Urine Testing Sales, by End-users K Units (2021-2026)
  • Table 431. Rest of South America Clinical Urine Testing Sales, by Methods K Units (2021-2026)
  • Table 432. Asia Pacific Clinical Urine Testing Sales, by Country K Units (2021-2026)
  • Table 433. Asia Pacific Clinical Urine Testing Sales, by Type K Units (2021-2026)
  • Table 434. Asia Pacific Clinical Urine Testing Sales, by Application K Units (2021-2026)
  • Table 435. Asia Pacific Clinical Urine Testing Sales, by End-users K Units (2021-2026)
  • Table 436. Asia Pacific Clinical Urine Testing Sales, by Methods K Units (2021-2026)
  • Table 437. China Clinical Urine Testing Sales, by Type K Units (2021-2026)
  • Table 438. China Clinical Urine Testing Sales, by Application K Units (2021-2026)
  • Table 439. China Clinical Urine Testing Sales, by End-users K Units (2021-2026)
  • Table 440. China Clinical Urine Testing Sales, by Methods K Units (2021-2026)
  • Table 441. Japan Clinical Urine Testing Sales, by Type K Units (2021-2026)
  • Table 442. Japan Clinical Urine Testing Sales, by Application K Units (2021-2026)
  • Table 443. Japan Clinical Urine Testing Sales, by End-users K Units (2021-2026)
  • Table 444. Japan Clinical Urine Testing Sales, by Methods K Units (2021-2026)
  • Table 445. India Clinical Urine Testing Sales, by Type K Units (2021-2026)
  • Table 446. India Clinical Urine Testing Sales, by Application K Units (2021-2026)
  • Table 447. India Clinical Urine Testing Sales, by End-users K Units (2021-2026)
  • Table 448. India Clinical Urine Testing Sales, by Methods K Units (2021-2026)
  • Table 449. South Korea Clinical Urine Testing Sales, by Type K Units (2021-2026)
  • Table 450. South Korea Clinical Urine Testing Sales, by Application K Units (2021-2026)
  • Table 451. South Korea Clinical Urine Testing Sales, by End-users K Units (2021-2026)
  • Table 452. South Korea Clinical Urine Testing Sales, by Methods K Units (2021-2026)
  • Table 453. Taiwan Clinical Urine Testing Sales, by Type K Units (2021-2026)
  • Table 454. Taiwan Clinical Urine Testing Sales, by Application K Units (2021-2026)
  • Table 455. Taiwan Clinical Urine Testing Sales, by End-users K Units (2021-2026)
  • Table 456. Taiwan Clinical Urine Testing Sales, by Methods K Units (2021-2026)
  • Table 457. Australia Clinical Urine Testing Sales, by Type K Units (2021-2026)
  • Table 458. Australia Clinical Urine Testing Sales, by Application K Units (2021-2026)
  • Table 459. Australia Clinical Urine Testing Sales, by End-users K Units (2021-2026)
  • Table 460. Australia Clinical Urine Testing Sales, by Methods K Units (2021-2026)
  • Table 461. Rest of Asia-Pacific Clinical Urine Testing Sales, by Type K Units (2021-2026)
  • Table 462. Rest of Asia-Pacific Clinical Urine Testing Sales, by Application K Units (2021-2026)
  • Table 463. Rest of Asia-Pacific Clinical Urine Testing Sales, by End-users K Units (2021-2026)
  • Table 464. Rest of Asia-Pacific Clinical Urine Testing Sales, by Methods K Units (2021-2026)
  • Table 465. Europe Clinical Urine Testing Sales, by Country K Units (2021-2026)
  • Table 466. Europe Clinical Urine Testing Sales, by Type K Units (2021-2026)
  • Table 467. Europe Clinical Urine Testing Sales, by Application K Units (2021-2026)
  • Table 468. Europe Clinical Urine Testing Sales, by End-users K Units (2021-2026)
  • Table 469. Europe Clinical Urine Testing Sales, by Methods K Units (2021-2026)
  • Table 470. Germany Clinical Urine Testing Sales, by Type K Units (2021-2026)
  • Table 471. Germany Clinical Urine Testing Sales, by Application K Units (2021-2026)
  • Table 472. Germany Clinical Urine Testing Sales, by End-users K Units (2021-2026)
  • Table 473. Germany Clinical Urine Testing Sales, by Methods K Units (2021-2026)
  • Table 474. France Clinical Urine Testing Sales, by Type K Units (2021-2026)
  • Table 475. France Clinical Urine Testing Sales, by Application K Units (2021-2026)
  • Table 476. France Clinical Urine Testing Sales, by End-users K Units (2021-2026)
  • Table 477. France Clinical Urine Testing Sales, by Methods K Units (2021-2026)
  • Table 478. Italy Clinical Urine Testing Sales, by Type K Units (2021-2026)
  • Table 479. Italy Clinical Urine Testing Sales, by Application K Units (2021-2026)
  • Table 480. Italy Clinical Urine Testing Sales, by End-users K Units (2021-2026)
  • Table 481. Italy Clinical Urine Testing Sales, by Methods K Units (2021-2026)
  • Table 482. United Kingdom Clinical Urine Testing Sales, by Type K Units (2021-2026)
  • Table 483. United Kingdom Clinical Urine Testing Sales, by Application K Units (2021-2026)
  • Table 484. United Kingdom Clinical Urine Testing Sales, by End-users K Units (2021-2026)
  • Table 485. United Kingdom Clinical Urine Testing Sales, by Methods K Units (2021-2026)
  • Table 486. Netherlands Clinical Urine Testing Sales, by Type K Units (2021-2026)
  • Table 487. Netherlands Clinical Urine Testing Sales, by Application K Units (2021-2026)
  • Table 488. Netherlands Clinical Urine Testing Sales, by End-users K Units (2021-2026)
  • Table 489. Netherlands Clinical Urine Testing Sales, by Methods K Units (2021-2026)
  • Table 490. Rest of Europe Clinical Urine Testing Sales, by Type K Units (2021-2026)
  • Table 491. Rest of Europe Clinical Urine Testing Sales, by Application K Units (2021-2026)
  • Table 492. Rest of Europe Clinical Urine Testing Sales, by End-users K Units (2021-2026)
  • Table 493. Rest of Europe Clinical Urine Testing Sales, by Methods K Units (2021-2026)
  • Table 494. MEA Clinical Urine Testing Sales, by Country K Units (2021-2026)
  • Table 495. MEA Clinical Urine Testing Sales, by Type K Units (2021-2026)
  • Table 496. MEA Clinical Urine Testing Sales, by Application K Units (2021-2026)
  • Table 497. MEA Clinical Urine Testing Sales, by End-users K Units (2021-2026)
  • Table 498. MEA Clinical Urine Testing Sales, by Methods K Units (2021-2026)
  • Table 499. Middle East Clinical Urine Testing Sales, by Type K Units (2021-2026)
  • Table 500. Middle East Clinical Urine Testing Sales, by Application K Units (2021-2026)
  • Table 501. Middle East Clinical Urine Testing Sales, by End-users K Units (2021-2026)
  • Table 502. Middle East Clinical Urine Testing Sales, by Methods K Units (2021-2026)
  • Table 503. Africa Clinical Urine Testing Sales, by Type K Units (2021-2026)
  • Table 504. Africa Clinical Urine Testing Sales, by Application K Units (2021-2026)
  • Table 505. Africa Clinical Urine Testing Sales, by End-users K Units (2021-2026)
  • Table 506. Africa Clinical Urine Testing Sales, by Methods K Units (2021-2026)
  • Table 507. North America Clinical Urine Testing Sales, by Country K Units (2021-2026)
  • Table 508. North America Clinical Urine Testing Sales, by Type K Units (2021-2026)
  • Table 509. North America Clinical Urine Testing Sales, by Application K Units (2021-2026)
  • Table 510. North America Clinical Urine Testing Sales, by End-users K Units (2021-2026)
  • Table 511. North America Clinical Urine Testing Sales, by Methods K Units (2021-2026)
  • Table 512. United States Clinical Urine Testing Sales, by Type K Units (2021-2026)
  • Table 513. United States Clinical Urine Testing Sales, by Application K Units (2021-2026)
  • Table 514. United States Clinical Urine Testing Sales, by End-users K Units (2021-2026)
  • Table 515. United States Clinical Urine Testing Sales, by Methods K Units (2021-2026)
  • Table 516. Canada Clinical Urine Testing Sales, by Type K Units (2021-2026)
  • Table 517. Canada Clinical Urine Testing Sales, by Application K Units (2021-2026)
  • Table 518. Canada Clinical Urine Testing Sales, by End-users K Units (2021-2026)
  • Table 519. Canada Clinical Urine Testing Sales, by Methods K Units (2021-2026)
  • Table 520. Mexico Clinical Urine Testing Sales, by Type K Units (2021-2026)
  • Table 521. Mexico Clinical Urine Testing Sales, by Application K Units (2021-2026)
  • Table 522. Mexico Clinical Urine Testing Sales, by End-users K Units (2021-2026)
  • Table 523. Mexico Clinical Urine Testing Sales, by Methods K Units (2021-2026)
  • Table 524. Clinical Urine Testing: by Type(USD/Units)
  • Table 525. Research Programs/Design for This Report
  • Table 526. Key Data Information from Secondary Sources
  • Table 527. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Clinical Urine Testing: by Type USD Million (2015-2020)
  • Figure 5. Global Clinical Urine Testing: by Application USD Million (2015-2020)
  • Figure 6. Global Clinical Urine Testing: by End-users USD Million (2015-2020)
  • Figure 7. Global Clinical Urine Testing: by Methods USD Million (2015-2020)
  • Figure 8. South America Clinical Urine Testing Share (%), by Country
  • Figure 9. Asia Pacific Clinical Urine Testing Share (%), by Country
  • Figure 10. Europe Clinical Urine Testing Share (%), by Country
  • Figure 11. MEA Clinical Urine Testing Share (%), by Country
  • Figure 12. North America Clinical Urine Testing Share (%), by Country
  • Figure 13. Global Clinical Urine Testing: by Type K Units (2015-2020)
  • Figure 14. Global Clinical Urine Testing: by Application K Units (2015-2020)
  • Figure 15. Global Clinical Urine Testing: by End-users K Units (2015-2020)
  • Figure 16. Global Clinical Urine Testing: by Methods K Units (2015-2020)
  • Figure 17. South America Clinical Urine Testing Share (%), by Country
  • Figure 18. Asia Pacific Clinical Urine Testing Share (%), by Country
  • Figure 19. Europe Clinical Urine Testing Share (%), by Country
  • Figure 20. MEA Clinical Urine Testing Share (%), by Country
  • Figure 21. North America Clinical Urine Testing Share (%), by Country
  • Figure 22. Global Clinical Urine Testing: by Type USD/Units (2015-2020)
  • Figure 23. Global Clinical Urine Testing share by Players 2020 (%)
  • Figure 24. Global Clinical Urine Testing share by Players (Top 3) 2020(%)
  • Figure 25. Global Clinical Urine Testing share by Players (Top 5) 2020(%)
  • Figure 26. BCG Matrix for key Companies
  • Figure 27. Siemens Healthineers AG (Germany) Revenue, Net Income and Gross profit
  • Figure 28. Siemens Healthineers AG (Germany) Revenue: by Geography 2020
  • Figure 29. Roche Holding AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 30. Roche Holding AG (Switzerland) Revenue: by Geography 2020
  • Figure 31. Beckman Coulter (United States) Revenue, Net Income and Gross profit
  • Figure 32. Beckman Coulter (United States) Revenue: by Geography 2020
  • Figure 33. Sysmex Corporation (Japan) Revenue, Net Income and Gross profit
  • Figure 34. Sysmex Corporation (Japan) Revenue: by Geography 2020
  • Figure 35. 77 Elektronika Kft. (Hungary) Revenue, Net Income and Gross profit
  • Figure 36. 77 Elektronika Kft. (Hungary) Revenue: by Geography 2020
  • Figure 37. Analyticon Biotechnologies AG (Germany) Revenue, Net Income and Gross profit
  • Figure 38. Analyticon Biotechnologies AG (Germany) Revenue: by Geography 2020
  • Figure 39. ERBA Diagnostics (United States) Revenue, Net Income and Gross profit
  • Figure 40. ERBA Diagnostics (United States) Revenue: by Geography 2020
  • Figure 41. ACON Laboratories, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 42. ACON Laboratories, Inc. (United States) Revenue: by Geography 2020
  • Figure 43. A. Menarini Diagnostics Ltd. (Italy) Revenue, Net Income and Gross profit
  • Figure 44. A. Menarini Diagnostics Ltd. (Italy) Revenue: by Geography 2020
  • Figure 45. URIT Medical Electronic Ltd. (China) Revenue, Net Income and Gross profit
  • Figure 46. URIT Medical Electronic Ltd. (China) Revenue: by Geography 2020
  • Figure 47. Global Clinical Urine Testing: by Type USD Million (2021-2026)
  • Figure 48. Global Clinical Urine Testing: by Application USD Million (2021-2026)
  • Figure 49. Global Clinical Urine Testing: by End-users USD Million (2021-2026)
  • Figure 50. Global Clinical Urine Testing: by Methods USD Million (2021-2026)
  • Figure 51. South America Clinical Urine Testing Share (%), by Country
  • Figure 52. Asia Pacific Clinical Urine Testing Share (%), by Country
  • Figure 53. Europe Clinical Urine Testing Share (%), by Country
  • Figure 54. MEA Clinical Urine Testing Share (%), by Country
  • Figure 55. North America Clinical Urine Testing Share (%), by Country
  • Figure 56. Global Clinical Urine Testing: by Type K Units (2021-2026)
  • Figure 57. Global Clinical Urine Testing: by Application K Units (2021-2026)
  • Figure 58. Global Clinical Urine Testing: by End-users K Units (2021-2026)
  • Figure 59. Global Clinical Urine Testing: by Methods K Units (2021-2026)
  • Figure 60. South America Clinical Urine Testing Share (%), by Country
  • Figure 61. Asia Pacific Clinical Urine Testing Share (%), by Country
  • Figure 62. Europe Clinical Urine Testing Share (%), by Country
  • Figure 63. MEA Clinical Urine Testing Share (%), by Country
  • Figure 64. North America Clinical Urine Testing Share (%), by Country
  • Figure 65. Global Clinical Urine Testing: by Type USD/Units (2021-2026)
List of companies from research coverage that are profiled in the study
  • Siemens Healthineers AG (Germany)
  • Roche Holding AG (Switzerland)
  • Beckman Coulter (United States)
  • Sysmex Corporation (Japan)
  • 77 Elektronika Kft. (Hungary)
  • Analyticon Biotechnologies AG (Germany)
  • ERBA Diagnostics (United States)
  • ACON Laboratories, Inc. (United States)
  • A. Menarini Diagnostics Ltd. (Italy)
  • URIT Medical Electronic Ltd. (China)
Additional players considered in the study are as follows:
Bio-Rad Laboratories (United States) , ACON Laboratories (United States)
Select User Access Type

Key Highlights of Report


Jun 2021 209 Pages 70 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

"Growing Global Prevalence of Kidney Diseases and Urinary Tract Infections " is seen as one of major growth factors of Clinical Urine Testing Market in years to come.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.

Know More About Global Clinical Urine Testing Market Report?